Considering How to Define Animal Models of Intrinsic Capacity in Aging

Key Takeaways

• WHO's intrinsic capacity lacks standardized measurement across studies
• New paper proposes mice and killifish for longitudinal IC tracking
• Behavioral tests must mirror human cognition, locomotion, vitality, sensory, psychological domains
• Animal models could speed discovery of therapies to maintain functional ability

Pulse Analysis

The World Health Organization’s intrinsic capacity construct has become a cornerstone of healthy‑aging policy, yet its practical application remains hampered by a proliferation of disparate measurement tools. Researchers have generated dozens of composite scores, each emphasizing different biomarkers or functional tests, which makes cross‑study comparison difficult and slows consensus building. This fragmentation underscores a broader challenge in geroscience: translating a high‑level concept into reproducible, quantitative data that can guide clinical decision‑making.

Animal models offer a pragmatic solution to this impasse. Mice, with a typical 2‑3‑year lifespan, and the turquoise killifish, which ages in 4‑6 months, enable researchers to observe entire aging trajectories within feasible timeframes. By designing behavioral paradigms—such as maze navigation for cognition, grip strength for locomotion, and stress‑induced assays for psychological resilience—that align with the five IC domains, scientists can generate longitudinal datasets that mirror human functional decline. Crucially, these assays must demonstrate a clear age‑related drop and sufficient signal‑to‑noise to differentiate subtle changes, ensuring relevance to human health outcomes.

The implications for drug development and public health are significant. With validated animal IC metrics, preclinical trials can more accurately assess whether candidate therapeutics preserve or restore functional ability, rather than merely extending lifespan. This functional focus aligns with the WHO’s goal of maximizing well‑being in older adults and could streamline regulatory pathways by providing concrete, domain‑specific efficacy endpoints. As the field coalesces around standardized animal models, the prospect of translating intrinsic capacity insights into actionable interventions becomes increasingly attainable, promising a new era of evidence‑based healthy‑aging strategies.